Export

Coagulation factor viii
Essential medicine status
General description
Factor VIII also known as anti-hemophilic A factor is used to treat and prevent bleeding in people with hemophilia A and other causes of low factor VIII.
Medicine type
Biological agent
EML status history
First added in 1979 (TRS 641) for Haemophilia A
Therapeutic equivalent for
Recommendations
Section
Blood coagulation factors
  • Parenteral > General injections > IV: 500 IU in vial powder for injection
Indications